Sissel Rodahl
Corporate Officer/Principal bij GENSIGHT BIOLOGICS S.A.
Actieve functies van Sissel Rodahl
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Corporate Officer/Principal | 31-01-2022 | - |
Loopbaan van Sissel Rodahl
Eerdere bekende functies van Sissel Rodahl
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | 01-09-2018 | 01-02-2022 |
Opleiding van Sissel Rodahl
| University of Oslo | Graduate Degree |
| Engineering College | Undergraduate Degree |
Statistieken
Internationaal
| Noorwegen | 3 |
| Frankrijk | 2 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Beurs
- Insiders
- Sissel Rodahl
- Ervaring
